Clinical trials for breast cancer
87 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 3
Breast cancer
#NCT06016738
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Centre Hospitalier de Compiègne (Compiègne), Centre Hospitalier Universitaire de Nantes (Nantes), Centre Jean Perrin (Clermont Ferrand ), Gustave Roussy (Villejuif), Centre Hospitalier du Mans (Le Mans) (and 1 more...)
Olema Pharmaceuticals, Inc.
Phase 3
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT06174987
Antibody Drug Conjugates (ADC)
Antibody Drug Conjugates (ADC)
Gustave Roussy (Villejuif)
Daiichi Sankyo
Phase 3
Breast cancer
#NCT05952557
HER2 Negative
HR Positive
Localized
Surgery
Chemotherapy
Radiotherapy
Hormone therapy
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Toulouse (Toulouse), Centre Hospitalier Universitaire de Nîmes (Nîmes), Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Gustave Roussy (Villejuif)
AstraZeneca
Phase 3
Breast cancer
#NCT06112379
HER2 Negative
HR Negative
Locally Advanced
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Radiotherapy
Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Institut du cancer de Montpellier (Montpellier), CHU Reims (Reims), Centre Hospitalier Universitaire de Toulouse (Toulouse) (and 2 more...)
AstraZeneca
Phase 3
Breast cancer
#NCT06018337
HER2 Low
HR Positive
Locally Advanced
Metastatic
Targeted therapy
Hormone therapy
Chemotherapy
Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), CHU Nîmes / Institut de cancérologie du Gard (Nîmes), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ), Centre Hospitalier Universitaire Dupuytren (Limoges) (and 11 more...)
DualityBio Inc.
Phase 3
Breast cancer
#NCT05894239
HER2 Positive
Locally Advanced
Metastatic
PIK3CA
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05696626
HER2 Negative
HR Positive
Locally Advanced
Metastatic
ESR
Targeted therapy
Hormone therapy
Other mutation
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille)
Sermonix Pharmaceuticals Inc.
Phase 3
Breast cancer
#NCT05296798
HER2 Positive
HR Positive
Locally Advanced
Metastatic
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre Hospitalier Universitaire de Grenoble (La Tronche) (and 4 more...)
Hoffmann-La Roche
Phase 3
Breast cancer
#NCT05514054
HER2 Negative
HR Positive
Localized
Hormone therapy
Institut Bergonié (Bordeaux), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique de Blois (La Chaussée-Saint-Victor), Groupe Hospitalier La Rochelle-Ré-Aunis (La Rochelle), Clinique Chénieux (Limoges) (and 31 more...)
Eli Lilly et compagnie
Phase 3
Breast cancer
#NCT05382286
HER2 Negative
HR Negative
Locally Advanced
Metastatic
Systemic Treatment-Naive
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Immunotherapy
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), Centre Hospitalier Universitaire de Besançon (Besançon), Polyclinique Bordeaux Nord Aquitaine (Bordeaux), Centre François Baclesse (Caen ), Centre Jean Perrin (Clermont Ferrand ) (and 9 more...)
Gilead Sciences